Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP12 | P39900 | 3/20 | 0.51 |
| ▸ | MMP13 | P45452 | 2/20 | 0.51 |
| ▸ | MMP2 | P08253 | 1/20 | 0.51 |
| ▸ | MMP9 | P14780 | 1/20 | 0.51 |
| ▸ | MMP14 | P50281 | 1/20 | 0.51 |
| ▸ | DPP4 | P27487 | 1/20 | 0.51 |
| ▸ | ANPEP | P15144 | 2/20 | 0.47 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.47 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.47 |
| ▸ | ACP3 | P15309 | 1/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.44 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.43 |
| ▸ | DHFR | P00374 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1139615 | 1.00 | MMP12 (0.51) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL9865316 | 0.90 | TRPA1 (0.51) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL4799370 | 0.84 | MMP2 (0.55) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL4980139 | 0.84 | DPP4 (0.45) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL15195459 | 0.84 | DPP4 (0.45) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL6695127 | 0.84 | MIF (0.46) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL7824406 | 0.81 | MMP12 (0.53) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL6692564 | 0.80 | FFAR1 (0.42) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL1138927 | 0.80 | FFAR1 (0.42) | MMP12MMP13MMP2MMP9MMP14 | |
| SCHEMBL4258875 | 0.80 | FFAR1 (0.42) | MMP12MMP13MMP2MMP9MMP14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7615233-B2 | Particulate construct comprising polyhydroxyalkanoate and method for producing it | CANON KABUSHIKI KAISHA (JP) | 2009-11-10 | — | — | US | disclosed |
| US-7527809-B2 | Polyhydroxyalkanoate-containing magnetic structure, and manufacturing method and use thereof | CANON KABUSHIKI KAISHA (JP) | 2009-05-05 | — | — | US | disclosed |
| EP-1275378-B1 | Particulate construct comprising polyhydroxyalkanoate and method for producing it | CANON KK (JP) | 2009-04-15 | — | — | EP | disclosed |
| EP-1253475-B1 | Electrostatic charge image developing toner, producing method therefor, and image forming method and image forming apparatus utilizing the toner | CANON KK (JP) | 2007-08-08 | — | — | EP | disclosed |
| US-7153622-B2 | Polyhydroxyalkanate overcoating a coloring agent | CANON KABUSHIKI KAISHA (JP) | 2006-12-26 | — | — | US | disclosed |
| US-20060263432-A1 | Useful as a sustained release pharmaceutical preparation; microcapsule stably containing a drug, especially a water-soluble drug at high content and which has magnetic property; drug delivery; excellent in dispersibility and magnetic response | CANON KABUSHIKI KAISHA (JP) | 2006-11-23 | — | — | US | disclosed |
| US-20040259026-A1 | Polyhydroxyalkanate overcoating a coloring agent | CANON KABUSHIKI KAISHA (JP) | 2004-12-23 | — | — | US | disclosed |
| WO-2004096188-A1 | POLYHYDROXYALKANOATE-CONTAINING MAGNETIC STRUCTURE, AND MANUFACTURING METHOD AND USE THEREOF | CANON KABUSHIKI KAISHA (JP) | 2004-11-11 | — | — | WO | disclosed |
| US-20030194443-A1 | Particulate construct comprising polyhydroxyalkanoate and method for producing it | CANON KABUSHIKI KAISHA (JP) | 2003-10-16 | — | — | US | disclosed |
| US-20030118931-A1 | Electrostatic charge image developing toner, producing method therefor, and image forming method and image forming apparatus utilizing the toner | CANON KABUSHIKI KAISHA (JP) | 2003-06-26 | — | — | US | disclosed |
| EP-1275378-A2 | Particulate construct comprising polyhydroxyalkanoate and method for producing it | CANON KABUSHIKI KAISHA (JP) | 2003-01-15 | — | — | EP | disclosed |
| EP-1253475-A2 | Electrostatic charge image developing toner, producing method therefor, and image forming method and image forming apparatus utilizing the toner | CANON KABUSHIKI KAISHA (JP) | 2002-10-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030194443-A1 | Particulate construct comprising polyhydroxyalkanoate and method for producing it | SQLE, FDFT1, CYP51A1 | MMP12 2452/4885MMP13 3300/4885MMP2 3651/4885 |
| US-20060263432-A1 | Useful as a sustained release pharmaceutical preparation; microcapsule stably containing a drug, especially a water-soluble drug at high content and which has magnetic property; drug delivery; excellent in dispersibility and magnetic response | SKP1, HAMP, AUP1 | MMP12 1385/4885MMP13 2546/4885MMP2 2874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.